SEPRAN S.A.S. - αποτελεσματα

suprecur 0,15 mg/dosis næsespray, opløsning

sanofi a/s - buserelinacetat - næsespray, opløsning - 0,15 mg/dosis

dymista 137+50 mikrog/dosis næsespray, suspension

paranova danmark a/s - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis

flixotide 125 mikrogram/dosis inhalationsspray, suspension

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationsspray, suspension - 125 mikrogram/dosis

flixotide 250 mikrogram/dosis inhalationsspray, suspension

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationsspray, suspension - 250 mikrogram/dosis

flixotide 50 mikrogram/dosis inhalationsspray, suspension

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationsspray, suspension - 50 mikrogram/dosis

lomudal nasal 5,2 mg/dosis næsespray, opløsning

sanofi a/s - natriumcromoglicat - næsespray, opløsning - 5,2 mg/dosis

syntocinon 6,7 mikrogram/dosis næsespray, opløsning

alfasigma s.p.a - oxytocin - næsespray, opløsning - 6,7 mikrogram/dosis

xylometazolin "teva" 1 mg/ml næsespray, opløsning

teva b.v. - xylometazolinhydrochlorid - næsespray, opløsning - 1 mg/ml

airflusal aerosol 25+125 mikrog./dosis inhalationsspray, suspension

2care4 aps - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+125 mikrog./dosis

flixotide 50 mikrogram/dosis inhalationsspray, suspension

chemvet pharma aps - fluticasonpropionat - inhalationsspray, suspension - 50 mikrogram/dosis